| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 23 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 264.1K | $2.38M | - | |
| CFO | 145.1K | $1.31M | - | |
| VP | 112.7K | $1.01M | - | |
| VP | 34.9K | $313.9K | - | |
| Dir | 28.5K | $256.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Glenn Gregory M88 | President, R&D | Sale+OE | 55,921 | $145.20 | $8,119,860.22 | -42.7% | |
| Aug 18, 2020 | Trizzino John86 | EVP, Cbo And CFO | Sale+OE | 42,788 | $148.78 | $6,366,182.45 | -14.1% | |
| Aug 18, 2020 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 46,242 | $144.33 | $6,673,982.40 | -67.6% | |
| Aug 18, 2020 | Evans Gary C | Director | Sale+OE | 10,500 | $150.44 | $1,579,620.00 | -3.2% | |
| Jun 18, 2020 | Glenn Gregory M88 | President, R&D | Sale+OE | 16,749 | $59.53 | $997,103.14 | -90.1% | |
| Jun 3, 2020 | Young James F82 | Director | Buy | 1,500 | $48.83 | $73,245.00 | New | |
| May 18, 2020 | Herrmann John A III91 | SVP, General Counsel | Sale+OE | 12,961 | $49.44 | $640,791.84 | -95.9% | |
| Jan 31, 2020 | Glenn Gregory M88 | President, R&D | Buy | 1,250 | $3.86 | $4,825.00 | +1,016% | |
| Nov 18, 2019 | McManus Michael A Jr81 | Director | Sell | 3,929 | $3.82 | $15,014.67 | -28.3% | |
| Sep 17, 2019 | Herrmann John A III91 | SVP, General Counsel | Sell | 3,643 | $7.07 | $25,756.74 | -100% |